SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-101811
Filing Date
2016-03-02
Accepted
2016-03-02 16:07:14
Documents
1
Period of Report
2016-03-02

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3383
  Complete submission text file 0001104659-16-101811.txt   4785
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 399 THORNALL STREET, 1ST FLOOR EDISON NJ 08837
Business Address
Sullivan-Bolyai John Z (Reporting) CIK: 0001668462 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36856 | Film No.: 161477127